FWM
ALXN

Focused Wealth Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Focused Wealth Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-40
Closed -$5K – 749
2016
Q3 		$5K Sell
40
-50
-56% -$6.44K ﹤0.01% 539
2016
Q2 		$11K Hold
90
– – 0.01% 433
2016
Q1 		$13K Hold
90
– – 0.01% 367
2015
Q4 		$17K Hold
90
– – 0.01% 338
2015
Q3 		$14K Hold
90
– – 0.01% 351
2015
Q2 		$16K Hold
90
– – 0.01% 343
2015
Q1 		$16K Hold
90
– – 0.01% 358
2014
Q4 		$17K Hold
90
– – 0.01% 336
2014
Q3 		$15K Sell
90
-40
-31% -$6.57K 0.01% 374
2014
Q2 		$20K Hold
130
– – 0.02% 314
2014
Q1 		$20K Sell
130
-130
-50% -$20.7K 0.02% 290
2013
Q4 		$35K Buy
260
+120
+86% +$14.4K 0.03% 207
2013
Q3 		$16K Buy
+140
New +$15.4K 0.02% 312

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return